Liquid Biopsy Market By Product Type (Assays and Kits, Instruments, and Services), By Application (Early Cancer Detection, Recurrence Monitoring, Prenatal Testing, Organ Transplant Monitoring, and Others), By Biomarker Type (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Microvesicles, and Others), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, and Others), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Prenatal Testing, and Others), and By End-User (Hospitals and Clinics, Diagnostic Laboratories, Pharma & Biotech Companies, and Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Global Liquid Biopsy Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising cancer cases boost liquid biopsy adoption for diagnostics.

3.2.2. Minimally invasive approach increases patient preference over tissue biopsies.

3.2.3. Precision medicine demands personalized, non-invasive liquid biopsy techniques.

3.3. Key industry pitfalls & challenges

3.3.1. Sensitivity challenges hinder detection of low-frequency cancer mutations.

3.3.2. Strict regulatory requirements slow the approval of new technologies.

3.3.3. High test costs limit liquid biopsy access in developing regions.

3.4. Market Opportunities

3.4.1. AI integration improves data accuracy and automated liquid biopsy diagnostics.

3.4.2. Emerging markets present growth potential with expanding healthcare infrastructure.

3.4.3. Multi-cancer detection creates opportunities for comprehensive early screening.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Pipeline Analysis

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Liquid Biopsy Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Assays and Kits

4.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

4.3. Instruments

4.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

4.4. Services

4.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

5. Liquid Biopsy Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Early Cancer Detection

5.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.3. Recurrence Monitoring

5.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.4. Prenatal Testing

5.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.5. Organ Transplant Monitoring

5.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

5.6. Others

5.6.1. Market Size and Forecast, By 2025-2035(USD Billion)

6. Liquid Biopsy Market, Biomarker Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Biomarker Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Circulating Tumor Cells (CTCs)

6.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

6.3. Circulating Tumor DNA (ctDNA)

6.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

6.4. Microvesicles

6.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

6.5. Others

6.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

7. Liquid Biopsy Market, Technology Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Technology, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Polymerase Chain Reaction (PCR)

7.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

7.3. Next-Generation Sequencing (NGS)

7.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

7.4. Microarray

7.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

7.5. Others

7.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

8. Liquid Biopsy Market, Indication Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Indication, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Lung Cancer

8.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.3. Breast Cancer

8.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.4. Colorectal Cancer

8.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.5. Prostate Cancer

8.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.6. Pancreatic Cancer

8.6.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.7. Prenatal testing

8.7.1. Market Size and Forecast, By 2025-2035(USD Billion)

8.8. Others

8.8.1. Market Size and Forecast, By 2025-2035(USD Billion)

9. Liquid Biopsy Market, End-User Segment Analysis

9.1. Overview

9.1.1. Market Revenue Share, By End-User, 2025 & 2035

9.1.2. Key Market Trends, Growth Factors, & Opportunities

9.2. Hospitals and Clinics

9.2.1. Market Size and Forecast, By 2025-2035(USD Billion)

9.3. Diagnostic Laboratories

9.3.1. Market Size and Forecast, By 2025-2035(USD Billion)

9.4. Pharma & Biotech Companies

9.4.1. Market Size and Forecast, By 2025-2035(USD Billion)

9.5. Research Institutes

9.5.1. Market Size and Forecast, By 2025-2035(USD Billion)

10. Liquid Biopsy Market, Region Segment Analysis

10.1. Overview

10.1.1. Global Market Revenue Share, By Region, 2025 & 2035

10.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

10.2. North America

10.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

10.2.2. North America Market Revenue, By Product Type, 2025-2035

10.2.3. North America Market Revenue, By Application, 2025-2035

10.2.4. North America Market Revenue, By Biomarker Type, 2025-2035

10.2.5. North America Market Revenue, By Technology, 2025-2035

10.2.6. North America Market Revenue, By Indication, 2025-2035

10.2.7. North America Market Revenue, By End-User, 2025-2035

10.2.8. The U.S.

10.2.8.1. U.S. Market Revenue, By Product Type, 2025-2035

10.2.8.2. U.S. Market Revenue, By Application, 2025-2035

10.2.8.3. U.S. Market Revenue, By Biomarker Type, 2025-2035

10.2.8.4. U.S. Market Revenue, By Technology, 2025-2035

10.2.8.5. U.S. Market Revenue, By Indication, 2025-2035

10.2.8.6. U.S. Market Revenue, By End-User, 2025-2035

10.2.9. Canada

10.2.9.1. Canada Market Revenue, By Product Type, 2025-2035

10.2.9.2. Canada Market Revenue, By Application, 2025-2035

10.2.9.3. Canada Market Revenue, By Biomarker Type, 2025-2035

10.2.9.4. Canada Market Revenue, By Technology, 2025-2035

10.2.9.5. Canada Market Revenue, By Indication, 2025-2035

10.2.9.6. Canada Market Revenue, By End-User, 2025-2035

10.3. Europe

10.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

10.3.2. Europe Market Revenue, By Product Type, 2025-2035

10.3.3. Europe Market Revenue, By Application, 2025-2035

10.3.4. Europe Market Revenue, By Biomarker Type, 2025-2035

10.3.5. Europe Market Revenue, By Technology, 2025-2035

10.3.6. Europe Market Revenue, By Indication, 2025-2035

10.3.7. Europe Market Revenue, By End-User, 2025-2035

10.3.8. Germany

10.3.8.1. Germany Market Revenue, By Product Type, 2025-2035

10.3.8.2. Germany Market Revenue, By Application, 2025-2035

10.3.8.3. Germany Market Revenue, By Biomarker Type, 2025-2035

10.3.8.4. Germany Market Revenue, By Technology, 2025-2035

10.3.8.5. Germany Market Revenue, By Indication, 2025-2035

10.3.8.6. Germany Market Revenue, By End-User, 2025-2035

10.3.9. France

10.3.9.1. France Market Revenue, By Product Type, 2025-2035

10.3.9.2. France Market Revenue, By Application, 2025-2035

10.3.9.3. France Market Revenue, By Biomarker Type, 2025-2035

10.3.9.4. France Market Revenue, By Technology, 2025-2035

10.3.9.5. France Market Revenue, By Indication, 2025-2035

10.3.9.6. France Market Revenue, By End-User, 2025-2035

10.3.10. U.K.

10.3.10.1. U.K. Market Revenue, By Product Type, 2025-2035

10.3.10.2. U.K. Market Revenue, By Application, 2025-2035

10.3.10.3. U.K Market Revenue, By Biomarker Type, 2025-2035

10.3.10.4. U.K Market Revenue, By Technology, 2025-2035

10.3.10.5. U.K Market Revenue, By Indication, 2025-2035

10.3.10.6. U.K. Market Revenue, By End-User, 2025-2035

10.3.11. Italy

10.3.11.1. Italy Market Revenue, By Product Type, 2025-2035

10.3.11.2. Italy Market Revenue, By Application, 2025-2035

10.3.11.3. Italy Market Revenue, By Biomarker Type, 2025-2035

10.3.11.4. Italy Market Revenue, By Technology, 2025-2035

10.3.11.5. Italy Market Revenue, By Indication, 2025-2035

10.3.11.6. Italy Market Revenue, By End-User, 2025-2035

10.3.12. Spain

10.3.12.1. Spain Market Revenue, By Product Type, 2025-2035

10.3.12.2. Spain Market Revenue, By Application, 2025-2035

10.3.12.3. Spain Market Revenue, By Biomarker Type, 2025-2035

10.3.12.4. Spain Market Revenue, By Technology, 2025-2035

10.3.12.5. Spain Market Revenue, By Indication, 2025-2035

10.3.12.6. Spain Market Revenue, By End-User, 2025-2035

10.3.13. Rest of Europe

10.3.13.1. Germany Market Revenue, By Product Type, 2025-2035

10.3.13.2. Germany Market Revenue, By Application, 2025-2035

10.3.13.3. Germany Market Revenue, By Biomarker Type, 2025-2035

10.3.13.4. Germany Market Revenue, By Technology, 2025-2035

10.3.13.5. Germany Market Revenue, By Indication, 2025-2035

10.3.13.6. Germany Market Revenue, By End-User, 2025-2035

10.4. Asia Pacific

10.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

10.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

10.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

10.4.4. Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

10.4.5. Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.6. Asia Pacific Market Revenue, By Indication, 2025-2035

10.4.7. Asia Pacific Market Revenue, By End-User, 2025-2035

10.4.8. China

10.4.8.1. China Market Revenue, By Product Type, 2025-2035

10.4.8.2. China Market Revenue, By Application, 2025-2035

10.4.8.3. China Market Revenue, By Biomarker Type, 2025-2035

10.4.8.4. China Market Revenue, By Technology, 2025-2035

10.4.8.5. China Market Revenue, By Indication, 2025-2035

10.4.8.6. China Market Revenue, By End-User, 2025-2035

10.4.9. Japan

10.4.9.1. Japan Market Revenue, By Product Type, 2025-2035

10.4.9.2. Japan Market Revenue, By Application, 2025-2035

10.4.9.3. Japan Market Revenue, By Biomarker Type, 2025-2035

10.4.9.4. Japan Market Revenue, By Technology, 2025-2035

10.4.9.5. Japan Market Revenue, By Indication, 2025-2035

10.4.9.6. Japan Market Revenue, By End-User, 2025-2035

10.4.10. India

10.4.10.1. India Market Revenue, By Product Type, 2025-2035

10.4.10.2. India Market Revenue, By Application, 2025-2035

10.4.10.3. India Market Revenue, By Biomarker Type, 2025-2035

10.4.10.4. India Market Revenue, By Technology, 2025-2035

10.4.10.5. India Market Revenue, By Indication, 2025-2035

10.4.10.6. India Market Revenue, By End-User, 2025-2035

10.4.11. Australia

10.4.11.1. Australia Market Revenue, By Product Type, 2025-2035

10.4.11.2. Australia Market Revenue, By Application, 2025-2035

10.4.11.3. Australia Market Revenue, By Biomarker Type, 2025-2035

10.4.11.4. Australia Market Revenue, By Technology, 2025-2035

10.4.11.5. Australia Market Revenue, By Indication, 2025-2035

10.4.11.6. Australia Market Revenue, By End-User, 2025-2035

10.4.12. South Korea

10.4.12.1. South Korea Market Revenue, By Product Type, 2025-2035

10.4.12.2. South Korea Market Revenue, By Application, 2025-2035

10.4.12.3. South Korea Market Revenue, By Biomarker Type, 2025-2035

10.4.12.4. South Korea Market Revenue, By Technology, 2025-2035

10.4.12.5. South Korea Market Revenue, By Indication, 2025-2035

10.4.12.6. South Korea Market Revenue, By End-User, 2025-2035

10.4.13. Singapore

10.4.13.1. Singapore Market Revenue, By Product Type, 2025-2035

10.4.13.2. Singapore Market Revenue, By Application, 2025-2035

10.4.13.3. Singapore Canada Market Revenue, By Biomarker Type, 2025-2035

10.4.13.4. Singapore Market Revenue, By Technology, 2025-2035

10.4.13.5. Singapore Market Revenue, By Indication, 2025-2035

10.4.13.6. Singapore Market Revenue, By End-User, 2025-2035

10.4.14. Rest of Asia Pacific

10.4.14.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

10.4.14.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

10.4.14.3. Rest of Asia Pacific Market Revenue, By Biomarker Type, 2025-2035

10.4.14.4. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.14.5. Rest of Asia Pacific Market Revenue, By Indication, 2025-2035

10.4.14.6. Rest of Asia Pacific Market Revenue, By End-User, 2025-2035

10.5. Latin America

10.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

10.5.2. Latin America Market Revenue, By Product Type, 2025-2035

10.5.3. Latin America Market Revenue, By Application, 2025-2035

10.5.4. Latin America Market Revenue, By Biomarker Type, 2025-2035

10.5.5. Latin America Market Revenue, By Technology, 2025-2035

10.5.6. Latin America Market Revenue, By Indication, 2025-2035

10.5.7. Latin America Market Revenue, By End-User, 2025-2035

10.5.7.1. Brazil Market Revenue, By Product Type, 2025-2035

10.5.7.2. Brazil Market Revenue, By Application, 2025-2035

10.5.7.3. Brazil Market Revenue, By Biomarker Type, 2025-2035

10.5.7.4. Brazil Market Revenue, By Technology, 2025-2035

10.5.7.5. Brazil Market Revenue, By Indication, 2025-2035

10.5.7.6. Brazil Market Revenue, By End-User, 2025-2035

10.5.8. Argentina

10.5.8.1. Argentina Market Revenue, By Product Type, 2025-2035

10.5.8.2. Argentina Market Revenue, By Application, 2025-2035

10.5.8.3. Argentina Market Revenue, By Biomarker Type, 2025-2035

10.5.8.4. Argentina Market Revenue, By Technology, 2025-2035

10.5.8.5. Argentina Market Revenue, By Indication, 2025-2035

10.5.8.6. Argentina Market Revenue, By End-User, 2025-2035

10.5.9. Mexico

10.5.9.1. Mexico Market Revenue, By Product Type, 2025-2035

10.5.9.2. Mexico Market Revenue, By Application, 2025-2035

10.5.9.3. Mexico Market Revenue, By Biomarker Type, 2025-2035

10.5.9.4. Mexico Market Revenue, By Technology, 2025-2035

10.5.9.5. Mexico Market Revenue, By Indication, 2025-2035

10.5.9.6. Mexico Market Revenue, By End-User, 2025-2035

10.5.10. Rest of Latin America

10.5.10.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

10.5.10.2. Rest of Latin America Market Revenue, By Application, 2025-2035

10.5.10.3. Rest of Latin America Market Revenue, By Biomarker Type, 2025-2035

10.5.10.4. Rest of Latin America Market Revenue, By Technology, 2025-2035

10.5.10.5. Rest of Latin America Market Revenue, By Indication, 2025-2035

10.5.10.6. Rest of Latin America Market Revenue, By End-User, 2025-2035

10.6. MEA

10.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

10.6.2. MEA Market Revenue, By Product Type, 2025-2035

10.6.3. MEA Market Revenue, By Application, 2025-2035

10.6.4. MEA Market Revenue, By Biomarker Type, 2025-2035

10.6.5. MEA Market Revenue, By Technology, 2025-2035

10.6.6. MEA Market Revenue, By Indication, 2025-2035

10.6.7. MEA Market Revenue, By End-User, 2025-2035

10.6.8. GCC Countries

10.6.8.1. GCC Countries Market Revenue, By Product Type, 2025-2035

10.6.8.2. GCC Countries Market Revenue, By Application, 2025-2035

10.6.8.3. GCC Countries Market Revenue, By Biomarker Type, 2025-2035

10.6.8.4. GCC Countries Market Revenue, By Technology, 2025-2035

10.6.8.5. GCC Countries Market Revenue, By Indication, 2025-2035

10.6.8.6. GCC Countries Market Revenue, By End-User, 2025-2035

10.6.9. South Africa

10.6.9.1. South Africa Countries Market Revenue, By Product Type, 2025-2035

10.6.9.2. South Africa Countries Market Revenue, By Application, 2025-2035

10.6.9.3. South Africa Countries Market Revenue, By Biomarker Type, 2025-2035

10.6.9.4. South Africa Countries Market Revenue, By Technology, 2025-2035

10.6.9.5. South Africa Countries Market Revenue, By Indication, 2025-2035

10.6.9.6. South Africa Countries Market Revenue, By End-User, 2025-2035

10.6.10. Rest of Middle-East Africa

10.6.10.1. Rest of Middle-East Africa Countries Market Revenue, By Product Type, 2025-2035

10.6.10.2. Rest of Middle-East Africa Countries Market Revenue, By Application, 2025-2035

10.6.10.3. Rest of Middle-East Africa Countries Market Revenue, By Biomarker Type, 2025-2035

10.6.10.4. Rest of Middle-East Africa Countries Market Revenue, By Technology, 2025-2035

10.6.10.5. Rest of Middle-East Africa Countries Market Revenue, By Indication, 2025-2035

10.6.10.6. Rest of Middle-East Africa Countries Market Revenue, By End-User, 2025-2035

11. Company Profile

11.1. Guardant Health, Inc.

11.1.1. Business Overview

11.1.2. Financial Performance

11.1.3. Product/Service Offerings

11.1.4. Strategies & recent developments

11.1.5. SWOT Analysis

11.2. Biocept, Inc.

11.2.1. Business Overview

11.2.2. Financial Performance

11.2.3. Product/Service Offerings

11.2.4. Strategies & recent developments

11.2.5. SWOT Analysis

11.3. Qiagen N.V.

11.3.1. Business Overview

11.3.2. Financial Performance

11.3.3. Product/Service Offerings

11.3.4. Strategies & recent developments

11.3.5. SWOT Analysis

11.4. F. Hoffmann-La Roche Ltd.

11.4.1. Business Overview

11.4.2. Financial Performance

11.4.3. Product/Service Offerings

11.4.4. Strategies & recent developments

11.4.5. SWOT Analysis

11.5. Thermo Fisher Scientific Inc.

11.5.1. Business Overview

11.5.2. Financial Performance

11.5.3. Product/Service Offerings

11.5.4. Strategies & recent developments

11.5.5. SWOT Analysis

11.6. Illumina, Inc.

11.6.1. Business Overview

11.6.2. Financial Performance

11.6.3. Product/Service Offerings

11.6.4. Strategies & recent developments

11.6.5. SWOT Analysis

11.7. Adaptive Biotechnologies Corporation

11.7.1. Business Overview

11.7.2. Financial Performance

11.7.3. Product/Service Offerings

11.7.4. Strategies & recent developments

11.7.5. SWOT Analysis

11.8. Exact Sciences Corporation

11.8.1. Business Overview

11.8.2. Financial Performance

11.8.3. Product/Service Offerings

11.8.4. Strategies & recent developments

11.8.5. SWOT Analysis

11.9. Freenome Holdings, Inc.

11.9.1. Business Overview

11.9.2. Financial Performance

11.9.3. Product/Service Offerings

11.9.4. Strategies & recent developments

11.9.5. SWOT Analysis

11.10. Natera, Inc.

11.10.1. Business Overview

11.10.2. Financial Performance

11.10.3. Product/Service Offerings

11.10.4. Strategies & recent developments

11.10.5. SWOT Analysis

11.11. Personal Genome Diagnostics, Inc.

11.11.1. Business Overview

11.11.2. Financial Performance

11.11.3. Product/Service Offerings

11.11.4. Strategies & recent developments

11.11.5. SWOT Analysis

11.12. MDxHealth SA

11.12.1. Business Overview

11.12.2. Financial Performance

11.12.3. Product/Service Offerings

11.12.4. Strategies & recent developments

11.12.5. SWOT Analysis

11.13. Grail, Inc.

11.13.1. Business Overview

11.13.2. Financial Performance

11.13.3. Product/Service Offerings

11.13.4. Strategies & recent developments

11.13.5. SWOT Analysis

11.14. Foundation Medicine, Inc.

11.14.1. Business Overview

11.14.2. Financial Performance

11.14.3. Product/Service Offerings

11.14.4. Strategies & recent developments

11.14.5. SWOT Analysis

11.15. Inivata Limited

11.15.1. Business Overview

11.15.2. Financial Performance

11.15.3. Product/Service Offerings

11.15.4. Strategies & recent developments

11.15.5. SWOT Analysis